Efficacy of Different Doses of Erythromycin in Premature Infants with Feeding Intolerance

ZHU Xu-liang,YANG Jia-chen,ZHANG Jun,LI Hai-zhen
DOI: https://doi.org/10.3969/j.issn.1000-2294.2013.04.012
2013-01-01
Abstract:Objective To explore the efficacy of different doses of erythromycin in the treatment of feeding intolerance(FI) in premature infants.Methods Ninety premature infants born between 2008 and 2010 were randomly divided into three groups,with 30 infants in each group.Group Ⅰ received conventional treatment only.GroupⅡand group Ⅲ were given erythromycin 5 mg·kg-1 qd and q12 h,respectively.Nutrition,growth and development indicators were compared among the three groups.Results Compared with groupⅠ,the time to daily calorie intakes of 209.5 kJ·kg-1 and 419.0 kJ·kg-1,time to regain birth weight,body weight,and rate of growth in head circumference and body length were significantly different from those in group Ⅱand group Ⅲ(P0.05),but there were no obvious differences between the two groups(P0.05).Conclusion Erythromycin can improve nutrition condition and promote early growth and development in premature infants.Different administration regimens are not correlated with therapeutic efficacy.
What problem does this paper attempt to address?